Genworth Financial Inc GNW
We take great care to ensure that the data presented and summarized in this overview for GENWORTH FINANCIAL INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GNW
View all-
Black Rock Inc. New York, NY62.9MShares$537 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA45.7MShares$390 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX26.5MShares$226 Million0.05% of portfolio
-
Donald Smith & Co., Inc. New York, NY25MShares$213 Million4.55% of portfolio
-
State Street Corp Boston, MA17.9MShares$153 Million0.01% of portfolio
-
River Road Asset Management, LLC16.6MShares$141 Million1.87% of portfolio
-
Geode Capital Management, LLC Boston, MA10.1MShares$86 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO9.57MShares$81.6 Million0.05% of portfolio
-
Nuveen, LLC Charlotte, NC9.56MShares$81.5 Million0.02% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.49MShares$55.4 Million0.04% of portfolio
Latest Institutional Activity in GNW
Top Purchases
Top Sells
About GNW
Genworth Financial, Inc. provides insurance products in the United States and internationally. The company operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The U.S. Life Insurance segment offers long-term care insurance products; and service traditional life insurance and fixed annuity products in the United States. The Runoff segment includes variable annuity, variable life insurance, and corporate-owned life insurance, as well as funding agreements. It distributes its products through sales force, in-house sales representatives, and digital marketing programs. The company was founded in 1871 and is headquartered in Richmond, Virginia.
Insider Transactions at GNW
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2025
|
Thomas J Mc Inerney President and CEO; Director |
SELL
Open market or private sale
|
Direct |
40,000
-0.78%
|
$320,000
$8.64 P/Share
|
|
Nov 24
2025
|
Gregory S. Karawan EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
40,000
-11.7%
|
$320,000
$8.51 P/Share
|
|
Nov 10
2025
|
Melissa Hagerman EVP and Chief HR Officer |
SELL
Bona fide gift
|
Direct |
3,513
-2.56%
|
-
|
|
Aug 27
2025
|
Rohit Gupta President & CEO, Enact |
SELL
Open market or private sale
|
Direct |
86,406
-9.81%
|
$691,248
$8.68 P/Share
|
|
Jul 11
2025
|
Samir B. Shah Pres. & CEO, CareScout Svcs. |
SELL
Payment of exercise price or tax liability
|
Direct |
8,160
-14.94%
|
$57,120
$7.32 P/Share
|
|
Jul 11
2025
|
Samir B. Shah Pres. & CEO, CareScout Svcs. |
BUY
Exercise of conversion of derivative security
|
Direct |
15,964
+22.62%
|
-
|
|
May 27
2025
|
Thomas J Mc Inerney President and CEO; Director |
SELL
Bona fide gift
|
Direct |
150,000
-3.08%
|
-
|
|
May 22
2025
|
G Kent Conrad |
BUY
Grant, award, or other acquisition
|
Direct |
23,681
+24.15%
|
$142,086
$6.97 P/Share
|
|
May 22
2025
|
Karen Elizabeth Dyson |
BUY
Grant, award, or other acquisition
|
Direct |
23,681
+24.15%
|
$142,086
$6.97 P/Share
|
|
May 22
2025
|
Jill R Goodman |
BUY
Grant, award, or other acquisition
|
Direct |
23,681
+24.15%
|
$142,086
$6.97 P/Share
|
|
May 22
2025
|
Melina E Higgins |
BUY
Grant, award, or other acquisition
|
Direct |
40,904
+23.63%
|
$245,424
$6.97 P/Share
|
|
May 22
2025
|
Howard D. Mills Iii |
BUY
Grant, award, or other acquisition
|
Direct |
23,681
+24.15%
|
$142,086
$6.97 P/Share
|
|
May 22
2025
|
Robert P Restrepo Jr |
BUY
Grant, award, or other acquisition
|
Direct |
23,681
+15.99%
|
$142,086
$6.97 P/Share
|
|
May 22
2025
|
Elaine A Sarsynski |
BUY
Grant, award, or other acquisition
|
Direct |
41,621
+23.85%
|
$249,726
$6.97 P/Share
|
|
May 22
2025
|
Ramsey D. Smith |
BUY
Grant, award, or other acquisition
|
Direct |
23,681
+24.15%
|
$142,086
$6.97 P/Share
|
|
May 22
2025
|
Steven C. Van Wyk |
BUY
Grant, award, or other acquisition
|
Direct |
41,621
+47.73%
|
$249,726
$6.97 P/Share
|
|
May 21
2025
|
Steven C. Van Wyk |
BUY
Grant, award, or other acquisition
|
Direct |
3,954
+50.0%
|
$23,724
$6.67 P/Share
|
|
Mar 03
2025
|
Thomas J Mc Inerney President and CEO; Director |
SELL
Payment of exercise price or tax liability
|
Direct |
290,264
-5.62%
|
$1,741,584
$6.96 P/Share
|
|
Mar 03
2025
|
Thomas J Mc Inerney President and CEO; Director |
BUY
Grant, award, or other acquisition
|
Direct |
635,220
+10.95%
|
-
|
|
Mar 03
2025
|
Jerome T Upton EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,013
-3.17%
|
$84,078
$6.96 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.11M shares |
|---|---|
| Exercise of conversion of derivative security | 538K shares |
| Open market or private sale | 166K shares |
|---|---|
| Payment of exercise price or tax liability | 545K shares |
| Bona fide gift | 154K shares |